Page 2 - Roche Alecensa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche s Alecensa lung cancer trial uses AI to find patients

Roche is looking for people with an error in a gene called ALK found in only about 4% to 5% of lung cancer patients, most of whom go undiagnosed.

Levi garrawayRoche alecensaCharlie fuchsMedial earlysign ltdEuropean society for medical oncologyChief medical officer levi garrawayMedial earlysignEuropean societyMedical oncology

Roche Taps AI to Find Lung Cancer Patients After Trial Success

Roche Taps AI to Find Lung Cancer Patients After Trial Success
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Levi garrawayRoche alecensaRoche holdingChief medical officer levi garraway

Roche taps AI to find lung cancer patients after trial success

Roche Holding AG s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificia.

Charlie fuchsRoche alecensaLevi garrawayEuropean society for medical oncologyRoche holdingMedial earlysign ltdChief medical officer levi garrawayMedial earlysignEuropean societyMedical oncologyThe peninsula

Roche Taps AI To Find Lung Cancer Patients After Trial Success

Roche Taps AI To Find Lung Cancer Patients After Trial Success
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Roche alecensaCharlie fuchsLevi garrawayMedial earlysign ltdEuropean society for medical oncologyRoche holdingChief medical officer levi garrawayMedial earlysignEuropean societyMedical oncology

Trial-first for Roche lung cancer ALK inhibitor

Trial-first for Roche lung cancer ALK inhibitor
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainLevi garrawayRoche tecentriqRoche alecensaHead of global product development at rocheEuropean commissionChief medical officerGlobal product development